| Literature DB >> 27704139 |
Utpal Bhadra1, Pradipta Patra1, Jagamohan Chhatai1, Manika Pal-Bhadra2.
Abstract
MicroRNAs (miRNAs) are well preserved in every animal. These pigmy sized non-coding RNAs (21-23 nt), scattered in genome, are responsible for micromanaging the versatile gene regulations. Involvement of miRNAs was surveillance cops in all human diseases including cardiovascular defects, tumor formation, reproductive pathways, and neurological and autoimmune disorders. The effective functional role of miRNA can be reduced by chemical entities of antisense oligonucleotides and versatile small molecules that support the views of novel therapy of different human diseases. In this study, we have updated our current understanding for designing and synthesizing miRNA-controlling therapeutic chemicals. We have also proposed various in-vivo delivery strategies and their ongoing challenges to combat the incorporation hurdles in live cells and animals. Lastly, we have demonstrated the current progress of miRNA modulation in the treatment of different human diseases that provides an alternative approach of gene therapy.Entities:
Keywords: autoimmune disorders; cardiovascular defects; microRNA; surveillance; tumor formation
Year: 2016 PMID: 27704139 PMCID: PMC5193465 DOI: 10.2119/molmed.2016.00136
Source DB: PubMed Journal: Mol Med ISSN: 1076-1551 Impact factor: 6.354